Back
Protagonist Therapeutics Vs. Freshpet Industry Stock Comparison
Buy
63
PTGX
Protagonist Therapeutics
Last Price:
29.93
Seasonality Move:
18.27%
Buy
61
FRPT
Freshpet
Last Price:
129.80
Seasonality Move:
8.16%
Buy
63
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $30.41. The Score for PTGX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Freshpet (FRPT)
is a Buy
Is Freshpet a Buy, Sell or Hold?
- The current Freshpet [FRPT] share price is $130.69. The Score for FRPT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- FRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $30.41
The current trend is moderately bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 59.39 | Buy |
| Chaikin Money Flow: | -238220 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.53 - 30.55) | Buy |
| Bollinger Bands (100): | (25.12 - 29.8) | Buy |
FRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.99 | Buy |
| Relative Strength Index (14 RSI): | 71.99 | Buy |
| Chaikin Money Flow: | 260674 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.72 - 126.74) | Buy |
| Bollinger Bands (100): | (90.13 - 117.87) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.22 | Sell |
| 20-day SMA: | 28.6 | Buy |
| 50-day SMA: | 27.89 | Buy |
| 200-day SMA: | 22.72 | Buy |
| 8-day EMA: | 30.62 | Sell |
| 20-day EMA: | 29.35 | Buy |
| 50-day EMA: | 28.19 | Buy |
| 200-day EMA: | 24.46 | Buy |
FRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 127.33 | Buy |
| 20-day SMA: | 120.24 | Buy |
| 50-day SMA: | 114.38 | Buy |
| 200-day SMA: | 87.2 | Buy |
| 8-day EMA: | 126.67 | Buy |
| 20-day EMA: | 121.74 | Buy |
| 50-day EMA: | 114.42 | Buy |
| 200-day EMA: | 93.39 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
Freshpet Earnings Growth & FRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.00 per share, an increase this year of $1.33 per share, and an increase next year of $0.38 per share.
Protagonist Therapeutics Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Freshpet Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||